These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 148121)

  • 21. Conversion of proteolytically modified form (Lys-form) of human plasminogen to plasmin by urokinase in the presence of tranexamic acid.
    Takada A; Takada Y
    Thromb Res; 1981 Aug 15-Sep 1; 23(4-5):411-9. PubMed ID: 6459659
    [No Abstract]   [Full Text] [Related]  

  • 22. Methods for determination of prekallikrein in plasma, glandular kallikrein and urokinase.
    Claeson G; Friberger P; Knös M; Eriksson E
    Haemostasis; 1978; 7(2-3):76-8. PubMed ID: 26629
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation pathway of glu-plasminogen to Lys-plasmin by urokinase.
    Takada A; Takada Y
    Thromb Res; 1982 Sep; 27(6):671-7. PubMed ID: 6129717
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fluorogenic fibrinogen and fibrin facilitate macromolecular assembly and dynamic assay of picomolar levels of plasminogen activators under well mixed conditions.
    Wu JH; Diamond SL
    Thromb Haemost; 1995 Aug; 74(2):711-7. PubMed ID: 8585011
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assay of coagulation proteases using peptide chromogenic and fluorogenic substrates.
    Lottenberg R; Christensen U; Jackson CM; Coleman PL
    Methods Enzymol; 1981; 80 Pt C():341-61. PubMed ID: 6210826
    [No Abstract]   [Full Text] [Related]  

  • 26. A sensitive colorimetric assay for various proteases using naphthyl ester derivatives as substrates.
    Niinobe M; Hitomi Y; Fujii S
    J Biochem; 1980 Mar; 87(3):779-83. PubMed ID: 6446549
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monoclonal antibodies inhibitory to human plasmin. Definitive demonstration of a role for plasmin in activating the proenzyme of urokinase-type plasminogen activator.
    Sim PS; Fayle DR; Doe WF; Stephens RW
    Eur J Biochem; 1986 Aug; 158(3):537-42. PubMed ID: 2942403
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fibrinolytic inhibitors from the experimental rat epithelioma.
    Mirowski M; Wierzbicki R
    Thromb Res; 1989 Jun; 54(5):457-65. PubMed ID: 2528218
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fibrinolysis and thrombosis of fibrinogen-modified gold nanoparticles for detection of fibrinolytic-related proteins.
    Jian JW; Chiu WC; Chang HT; Hsu PH; Huang CC
    Anal Chim Acta; 2013 Apr; 774():67-72. PubMed ID: 23567118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kinetic studies of urokinase-catalysed hydrolysis of 5-oxo-L-prolylglycyl-L-arginine 4-nitroanilide.
    Ipsen HH; Christensen U
    Biochim Biophys Acta; 1980 Jun; 613(2):476-81. PubMed ID: 6449958
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Different molecular forms of plasminogen and plasmin produced by urokinase in human plasma and their relation to protease inhibitors and lysis of fibrinogen and fibrin.
    Müllertz S
    Biochem J; 1974 Nov; 143(2):273-83. PubMed ID: 4282470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proceedings: "Different" forms of urokinase.
    Vukovich T; Binder B; Auerswald W
    Thromb Diath Haemorrh; 1975 Sep; 34(1):338. PubMed ID: 1188770
    [No Abstract]   [Full Text] [Related]  

  • 33. Action of crotalase, an enzyme with thrombin-like and kallikrein-like specificities, on tripeptide nitroanilide derivatives.
    Simmons G; Bundalian M; Theodor I; Martinoli J; Pirkle H
    Thromb Res; 1985 Nov; 40(4):555-61. PubMed ID: 2934864
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assay of urokinase activity in plasma with a chromogenic substrate.
    Hayashi S; Yamada K
    Thromb Res; 1981 Jun 1-25; 22(5-6):573-8. PubMed ID: 6171046
    [No Abstract]   [Full Text] [Related]  

  • 35. Assay of functional plasminogen in rat plasma applicable to experimental studies of thrombolysis.
    Bangert K; Thorsen S
    Thromb Haemost; 2000 Aug; 84(2):299-306. PubMed ID: 10959704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chromogenic assay for equine plasminogen.
    Welles EG; Prasse KW; Duncan A
    Am J Vet Res; 1990 Jul; 51(7):1080-5. PubMed ID: 1697146
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kinetics of reciprocal pro-urokinase/plasminogen activation--stimulation by a template formed by the urokinase receptor bound to poly(D-lysine).
    Petersen LC
    Eur J Biochem; 1997 Apr; 245(2):316-23. PubMed ID: 9151959
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative determination of plasmin: a fibrinogenolytic method.
    Vukovich T
    Clin Chim Acta; 1977 Sep; 79(2):285-90. PubMed ID: 142589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vascular extracellular matrix remodeling in cerebral aneurysms.
    Bruno G; Todor R; Lewis I; Chyatte D
    J Neurosurg; 1998 Sep; 89(3):431-40. PubMed ID: 9724118
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fibrin suspension as a substrate fop plasmin: determination and kinetics.
    Kanai S; Okamoto H; Tamaura Y; Yamazaki S; Inada Y
    Thromb Haemost; 1979 Dec; 42(4):1153-8. PubMed ID: 161668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.